Executive Summary On August 22, 2014, the Drug Enforcement Administration (“DEA”) released its final rule rescheduling hydrocodone combination products (“HCPs”) from Schedule III to Schedule II of the Controlled Substances Act (“Final Rule”). This Final Rule went into effect on October 6, 2014 and applies to all persons who manufacture, distribute, dispense, import, export, engage…Read More
DEA Final Rule Reschedules Hydrocodone Combination Products from Schedule III to Schedule II
Posted on October 10, 2014 in Health Law News
Published by: Hall Render